Oral Anticoagulants: Their role in AF management
There is a largely under-appreciated AF (inclusive non-valvular AF) prevalence in Australia.
It is estimated that 5.35% of the adult population aged ≥ 55 years are affected by AF.
Opportunistic screening for silent AF seems cost-effective in elderly patients, and similar effects reported using single-lead ECG screening in other at-risk populations.
Missed diagnoses or sub-optimal management of AF leads to patients who have significantly poorer quality of life, experiencing symptoms such as lethargy, palpitations, dyspnoea, chest tightness, sleeping difficulties and more.
By completing this audit, GPs will be able to:
- Proactively identify AF patients and engage in conversation regarding oral anticoagulant (OAC) options
- Improve your understanding of safety evidence for OACs and how they inform treatment decisions and subsequent management
- Improve understanding of the importance and relevance of OAC reversal in emergencies
On successful completion, GPs will be eligible for 40 Category 1 points from the RACGP or 30 PRPD points from ACRRM. This audit qualifies as a Quality Improvement activity.
Please click here to start the audit.